Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Space GlucoseControl system for blood glucose control in intensive care patients--a European multicentre observational study.

Blaha J, Barteczko-Grajek B, Berezowicz P, Charvat J, Chvojka J, Grau T, Holmgren J, Jaschinski U, Kopecky P, Manak J, Moehl M, Paddle J, Pasculli M, Petersson J, Petros S, Radrizzani D, Singh V, Starkopf J.

BMC Anesthesiol. 2016 Jan 22;16:8. doi: 10.1186/s12871-016-0175-4.

2.

Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries.

Krag M, Perner A, Wetterslev J, Wise MP, Borthwick M, Bendel S, McArthur C, Cook D, Nielsen N, Pelosi P, Keus F, Guttormsen AB, Moller AD, Møller MH; SUP-ICU Collaborators.

Acta Anaesthesiol Scand. 2015 May;59(5):576-85. doi: 10.1111/aas.12508.

PMID:
25880349
3.

Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients.

Krag M, Perner A, Wetterslev J, Wise MP, Borthwick M, Bendel S, McArthur C, Cook D, Nielsen N, Pelosi P, Keus F, Guttormsen AB, Moller AD, Møller MH; SUP-ICU co-authors.

Intensive Care Med. 2015 May;41(5):833-45. doi: 10.1007/s00134-015-3725-1. Epub 2015 Apr 10.

PMID:
25860444
4.

Lower versus higher hemoglobin threshold for transfusion in septic shock.

Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, Johansson PI, Aneman A, Vang ML, Winding R, Nebrich L, Nibro HL, Rasmussen BS, Lauridsen JR, Nielsen JS, Oldner A, Pettilä V, Cronhjort MB, Andersen LH, Pedersen UG, Reiter N, Wiis J, White JO, Russell L, Thornberg KJ, Hjortrup PB, Müller RG, Møller MH, Steensen M, Tjäder I, Kilsand K, Odeberg-Wernerman S, Sjøbø B, Bundgaard H, Thyø MA, Lodahl D, Mærkedahl R, Albeck C, Illum D, Kruse M, Winkel P, Perner A; TRISS Trial Group; Scandinavian Critical Care Trials Group.

N Engl J Med. 2014 Oct 9;371(15):1381-91. doi: 10.1056/NEJMoa1406617. Epub 2014 Oct 1.

5.

Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome.

De Waele J, Lipman J, Sakr Y, Marshall JC, Vanhems P, Barrera Groba C, Leone M, Vincent JL; EPIC II Investigators.

BMC Infect Dis. 2014 Jul 29;14:420. doi: 10.1186/1471-2334-14-420.

6.

Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study.

Gustot T, Felleiter P, Pickkers P, Sakr Y, Rello J, Velissaris D, Pierrakos C, Taccone FS, Sevcik P, Moreno C, Vincent JL; EPIC II Group of Investigators.

Liver Int. 2014 Nov;34(10):1496-503. doi: 10.1111/liv.12520. Epub 2014 Mar 26.

PMID:
24606193
7.

Transfusion requirements in septic shock (TRISS) trial - comparing the effects and safety of liberal versus restrictive red blood cell transfusion in septic shock patients in the ICU: protocol for a randomised controlled trial.

Holst LB, Haase N, Wetterslev J, Wernerman J, Aneman A, Guttormsen AB, Johansson PI, Karlsson S, Klemenzson G, Winding R, Nebrich L, Albeck C, Vang ML, Bülow HH, Elkjær JM, Nielsen JS, Kirkegaard P, Nibro H, Lindhardt A, Strange D, Thormar K, Poulsen LM, Berezowicz P, Bådstøløkken PM, Strand K, Cronhjort M, Haunstrup E, Rian O, Oldner A, Bendtsen A, Iversen S, Langva JÅ, Johansen RB, Nielsen N, Pettilä V, Reinikainen M, Keld D, Leivdal S, Breider JM, Tjäder I, Reiter N, Gøttrup U, White J, Wiis J, Andersen LH, Steensen M, Perner A.

Trials. 2013 May 23;14:150. doi: 10.1186/1745-6215-14-150.

8.

Quality of life and pruritus in patients with severe sepsis resuscitated with hydroxyethyl starch long-term follow-up of a randomised trial.

Wittbrodt P, Haase N, Butowska D, Winding R, Poulsen JB, Perner A; 6S trial group; Scandinavian Critical Care Trials Group.

Crit Care. 2013 Feb 25;17(2):R58. doi: 10.1186/cc12586.

9.

Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.

Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J; 6S Trial Group; Scandinavian Critical Care Trials Group.

N Engl J Med. 2012 Jul 12;367(2):124-34. doi: 10.1056/NEJMoa1204242. Epub 2012 Jun 27. Erratum in: N Engl J Med. 2012 Aug 2;367(5):481.

10.

Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial.

Perner A, Haase N, Wetterslev J, Aneman A, Tenhunen J, Guttormsen AB, Klemenzson G, Pott F, Bødker KD, Bådstøløkken PM, Bendtsen A, Søe-Jensen P, Tousi H, Bestle M, Pawlowicz M, Winding R, Bülow HH, Kancir C, Steensen M, Nielsen J, Fogh B, Madsen KR, Larsen NH, Carlsson M, Wiis J, Petersen JA, Iversen S, Schøidt O, Leivdal S, Berezowicz P, Pettilä V, Ruokonen E, Klepstad P, Karlsson S, Kaukonen M, Rutanen J, Karason S, Kjældgaard AL, Holst LB, Wernerman J; Scandinavian Critical Care Trials Group.

Trials. 2011 Jan 27;12:24. doi: 10.1186/1745-6215-12-24.

11.

Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study.

Kett DH, Azoulay E, Echeverria PM, Vincent JL; Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators.

Crit Care Med. 2011 Apr;39(4):665-70. doi: 10.1097/CCM.0b013e318206c1ca.

PMID:
21169817
12.

Lactoferrin effects on the in vitro immune response in critically ill patients.

Adamik B, Zimecki M, Właszczyk A, Berezowicz P, Kübler A.

Arch Immunol Ther Exp (Warsz). 1998;46(3):169-76.

PMID:
9704149
13.

[A case of HELLP syndrome complicated by acute renal failure and acute respiratory failure].

Kaiser T, Berezowicz PS, Duszyńska W, Kübler A.

Pol Merkur Lekarski. 1996 Oct;1(4):276-7. Polish.

PMID:
9156945
14.

[Interleukins 4 and 5--factors regulating the activity of the immune system].

Berezowicz PS.

Postepy Hig Med Dosw. 1991;45(1-2):17-44. Review. Polish. No abstract available.

PMID:
1923995
15.

[New members of the interleukin family: interleukins 6 and 7].

Berezowicz PS.

Postepy Hig Med Dosw. 1991;45(6):405-17. Review. Polish. No abstract available.

PMID:
1813882
16.

[Interleukin 3--biochemical properties and biological activities].

Berezowicz PS.

Postepy Hig Med Dosw. 1990;44(4-6):181-216. Review. Polish. No abstract available.

PMID:
2097607

Supplemental Content

Loading ...
Support Center